L. Pache

1.8k total citations
21 papers, 1.5k citations indexed

About

L. Pache is a scholar working on Cancer Research, Oncology and Reproductive Medicine. According to data from OpenAlex, L. Pache has authored 21 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 11 papers in Oncology and 8 papers in Reproductive Medicine. Recurrent topics in L. Pache's work include Protease and Inhibitor Mechanisms (9 papers), Ovarian cancer diagnosis and treatment (8 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). L. Pache is often cited by papers focused on Protease and Inhibitor Mechanisms (9 papers), Ovarian cancer diagnosis and treatment (8 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). L. Pache collaborates with scholars based in Germany, Switzerland and Estonia. L. Pache's co-authors include F. Jänicke, H. Graeff, Manfred Schmitt, Nadia Harbeck, Heinz Höfler, P. Dettmar, Kurt Ulm, W. Eiermann, Michael Untch and W. Kühn and has published in prestigious journals such as Cancer, British Journal of Cancer and European Journal of Cancer.

In The Last Decade

L. Pache

20 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Pache Germany 15 843 615 396 281 246 21 1.5k
K Späthe Germany 8 298 0.4× 266 0.4× 242 0.6× 275 1.0× 114 0.5× 9 800
Birgit M. Kräling United States 10 551 0.7× 739 1.2× 986 2.5× 58 0.2× 128 0.5× 12 1.9k
Bernhard Barleon Germany 14 577 0.7× 421 0.7× 1.3k 3.3× 35 0.1× 74 0.3× 17 1.7k
Carla A. Borgoño Canada 24 413 0.5× 785 1.3× 725 1.8× 106 0.4× 735 3.0× 31 2.3k
E. Lynette Wilson United States 20 425 0.5× 560 0.9× 747 1.9× 35 0.1× 129 0.5× 38 1.6k
L Martín United Kingdom 10 446 0.5× 355 0.6× 682 1.7× 25 0.1× 57 0.2× 14 1.1k
Brian P. Adley United States 22 313 0.4× 347 0.6× 724 1.8× 124 0.4× 20 0.1× 30 1.5k
Behrouz Zand United States 12 143 0.2× 350 0.6× 364 0.9× 86 0.3× 83 0.3× 34 869
P. Birner Austria 21 459 0.5× 606 1.0× 683 1.7× 48 0.2× 29 0.1× 42 1.5k
Davide Nicoli Italy 23 139 0.2× 228 0.4× 377 1.0× 43 0.2× 100 0.4× 72 1.4k

Countries citing papers authored by L. Pache

Since Specialization
Citations

This map shows the geographic impact of L. Pache's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Pache with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Pache more than expected).

Fields of papers citing papers by L. Pache

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Pache. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Pache. The network helps show where L. Pache may publish in the future.

Co-authorship network of co-authors of L. Pache

This figure shows the co-authorship network connecting the top 25 collaborators of L. Pache. A scholar is included among the top collaborators of L. Pache based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Pache. L. Pache is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Woitowitz, H.‐J., H. LANGE, K. Rödelsperger, et al.. (2008). Berufskrebsstudie Asbest: Möglichkeiten und Grenzen epidemiologischer Todesursachenforschung in der Bundesrepublik Deutschland*. DMW - Deutsche Medizinische Wochenschrift. 111(13). 490–499.
3.
Kühn, W., Barbara Schmalfeldt, Ute Reuning, et al.. (1999). Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc. British Journal of Cancer. 79(11-12). 1746–1751. 110 indexed citations
4.
Kühn, W., G. Florack, J. D. Roder, et al.. (1998). The influence of upper abdominal surgery on perioperative morbidity and mortality in patients with advanced ovarian cancer FIGO III and FIGO IV. International Journal of Gynecological Cancer. 8(1). 56–63. 45 indexed citations
5.
Kühn, W., Barbara Schmalfeldt, L. Pache, et al.. (1998). Disease-adapted relapse therapy for ovarian cancer: results of a prospective study.. PubMed. 13(1). 57–63. 20 indexed citations
6.
Kühn, W., Barbara Schmalfeldt, L. Pache, et al.. (1998). Disease-adapted relapse therapy for ovarian cancer: results of a prospective study.. International Journal of Oncology. 14 indexed citations
7.
Dettmar, P., Nadia Harbeck, Christoph Thomssen, et al.. (1997). Prognostic impact of proliferation-associated factors MIB1 (Ki-67) and S-phase in node-negative breast cancer. British Journal of Cancer. 75(10). 1525–1533. 65 indexed citations
8.
Thomssen, Christoph, P. Dettmar, L. Pache, et al.. (1997). Long-term prognostic impact of PAI-1 in primary breast cancer confirmed by six-year median follow-up. European Journal of Cancer. 33. S194–S194. 1 indexed citations
9.
Kühn, W., Barbara Schmalfeldt, J. Dose, et al.. (1996). Die intravenöse oder orale Etoposid-Therapie des Platin-refraktären Ovarialkarzinom-Frührezidivs. Geburtshilfe und Frauenheilkunde. 56(2). 105–110. 10 indexed citations
10.
Schmalfeldt, Barbara, W. Kühn, Ute Reuning, et al.. (1995). Primary tumor and metastasis in ovarian cancer differ in their content of urokinase-type plasminogen activator, its receptor, and inhibitors types 1 and 2.. PubMed. 55(18). 3958–63. 85 indexed citations
11.
Harbeck, Nadia, P. Dettmar, L. Pache, et al.. (1995). Prognostische Bedeutung der Proliferationsparameter S-Phase und MIB1 (Ki-67) beim nodal-negativen Mammakarzinom. Gyn�kologisch-geburtshilfliche Rundschau. 35(1). 142–147. 2 indexed citations
12.
Thomssen, Christoph, Manfred Schmitt, Lothar Goretzki, et al.. (1995). Prognostic value of the cysteine proteases cathepsins B and cathepsin L in human breast cancer.. PubMed. 1(7). 741–6. 111 indexed citations
13.
Kühn, W., L. Pache, Barbara Schmalfeldt, et al.. (1994). Urokinase (uPA) and PAI-1 Predict Survival in Advanced Ovarian Cancer Patients (FIGO III) after Radical Surgery and Platinum-Based Chemotherapy. Gynecologic Oncology. 55(3). 401–409. 114 indexed citations
14.
Harbeck, Nadia, Michael Untch, L. Pache, & W. Eiermann. (1994). Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up. British Journal of Cancer. 69(3). 566–571. 182 indexed citations
15.
Jänicke, F., Manfred Schmitt, L. Pache, et al.. (1993). Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer. Breast Cancer Research and Treatment. 24(3). 195–208. 298 indexed citations
16.
Kühn, W., F. Jänicke, L. Pache, et al.. (1993). Entwicklungen in der Therapie des fortgeschrittenen Ovarialkarzinoms FIGO III. Geburtshilfe und Frauenheilkunde. 53(5). 293–302. 7 indexed citations
17.
Schmitt, Max, F. Jänicke, Christoph Thomssen, et al.. (1993). Prognostic value of urokinase-type plasminogen activator (UPA) and its inhibitor PAI-1 in breast cancer. European Journal of Cancer. 29. S31–S31. 2 indexed citations
18.
Schmitt, Mark R., F. Jänicke, Nobuhiko Moniwa, et al.. (1992). Tumor-Associated Urokinase-Type Plasminogen Activator: Biological and Clinical Significance. Biological Chemistry Hoppe-Seyler. 373(2). 611–622. 105 indexed citations
19.
Jänicke, F., et al.. (1992). Radical surgical procedure improves survival time in patients with recurrent ovarian cancer. Cancer. 70(8). 2129–2136. 152 indexed citations
20.
Woitowitz, H.‐J., et al.. (1986). Mortality rates in the Federal Republic of Germany following previous occupational exposure to asbestos dust. International Archives of Occupational and Environmental Health. 57(3). 161–171. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K Späthe Breakdown of academic impact, for papers by Birgit M. Kräling Breakdown of academic impact, for papers by Bernhard Barleon Breakdown of academic impact, for papers by Carla A. Borgoño Breakdown of academic impact, for papers by E. Lynette Wilson Breakdown of academic impact, for papers by L Martín Breakdown of academic impact, for papers by Brian P. Adley Breakdown of academic impact, for papers by Behrouz Zand Breakdown of academic impact, for papers by P. Birner Breakdown of academic impact, for papers by Davide Nicoli
Rankless by CCL
2026